Gian Life Care Ltd - Stock Valuation and Financial Performance

BSE: 542918 | NSE: | Hospital & Healthcare Services | Small Cap

Gian Life Care Share Price

18.64 -0.30 -1.58%
as on 21-Nov'24 16:59

DeciZen - make an informed investing decision on Gian Life Care

M-Cap below 100cr DeciZen not available

Gian Life Care stock performance -

mw4me loader
P/E Ratio (SA):
4.80
Market Cap:
19.6 Cr.
52-wk low:
17
52-wk high:
29

Is Gian Life Care Ltd an attractive stock to invest in?

1. Is Gian Life Care Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Gian Life Care Ltd is a good quality company.

2. Is Gian Life Care Ltd undervalued or overvalued?

The key valuation ratios of Gian Life Care Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.

3. Is Gian Life Care Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Gian Life Care Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Gian Life Care:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Gian Life Care Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation

Value Creation Index Colour Code Guide

Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
ROCE % 12.3%42.5%35.9%53.2%12.4%29.2%-
Value Creation
Index
-0.12.01.62.8-0.11.1-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 0.67.710.515.911.913.112
Sales YoY Gr.-1,266.1%36.7%52.3%-25.2%10.1%-
Adj EPS 0.21.124.21.24.23.9
YoY Gr.-373.9%78.9%116.9%-71.2%240.2%-
BVPS (₹) 0.37.49.313.614.81919.2
Adj Net
Profit
0.11.124.41.34.34
Cash Flow from Ops. 31.52.95.82.30.8-
Debt/CF from Ops. 0.50.70.40.425.5-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NA87.9%7.9%10.1%
Adj EPS NA78.4%28.6%240.2%
BVPSNA137.7%26.6%28.1%
Share Price - - -26.9% -5.9%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
Return on
Equity %
90.929.123.336.98.624.620.6
Op. Profit
Mgn %
3530.333.343.517.147.347
Net Profit
Mgn %
1814.719.327.510.532.733.1
Debt to
Equity
12.30.10.10.10.30.20.1
Working Cap
Days
0291321281496545244
Cash Conv.
Cycle
0-13-2-47-38-17768

Recent Performance Summary

Net Profit is growing at healthy rate in last 3 years 28.63%

Sales growth is good in last 4 quarters at 34.37%

Return on Equity has declined versus last 3 years average to 21.00%

Sales growth has been subdued in last 3 years 7.85%

Latest Financials - Gian Life Care Ltd.

Standalone Consolidated
TTM EPS (₹) 3.9 3.8
TTM Sales (₹ Cr.) 12.3 12.3
BVPS (₹.) 19.2 18.8
Reserves (₹ Cr.) 10 9
P/BV 0.99 1.00
PE 4.80 5.03
From the Market
52 Week Low / High (₹) 17.01 / 29.00
All Time Low / High (₹) 5.48 / 65.91
Market Cap (₹ Cr.) 19.6
Equity (₹ Cr.) 10.3
Face Value (₹) 10
Industry PE 40.5

Management X-Ray of Gian Life Care:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.0026.530.0062.27
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Gian Life Care

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Sales0.567.6510.4615.9311.9213.12
Operating Expenses 0.365.336.9899.886.91
Manufacturing Costs0.020.230.260.400.470.32
Material Costs0.071.593.572.822.761.76
Employee Cost 0.111.020.941.311.580.91
Other Costs 0.172.492.204.475.073.92
Operating Profit 0.202.323.486.932.046.21
Operating Profit Margin (%) 35.0%30.3%33.3%43.5%17.1%47.3%
Other Income 00.100.290.510.690.64
Interest 0.040.610.731.250.450.47
Depreciation 0.020.260.290.330.500.46
Exceptional Items 000000
Profit Before Tax 0.141.562.755.851.795.91
Tax 0.040.430.741.480.531.62
Profit After Tax 0.101.132.024.371.264.30
PAT Margin (%) 18.0%14.7%19.3%27.5%10.5%32.7%
Adjusted EPS (₹)0.21.12.04.21.24.2
Dividend Payout Ratio (%)0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'19Mar'20Mar'21Mar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund 0.117.649.6614.0315.3119.62
Share Capital 0.014.704.7010.3410.3410.34
Reserves 0.102.944.963.694.979.27
Minority Interest000000
Debt0.980.790.671.874.343.69
Long Term Debt0.980.750.621.871.651.80
Short Term Debt00.040.0502.691.89
Trade Payables1.011.111.631.552.873.07
Others Liabilities 5.722.833.525.615.875.69
Total Liabilities 7.8212.3715.4823.0628.4032.07

Fixed Assets

Gross Block2.933.123.554.3866.31
Accumulated Depreciation0.020.280.560.891.391.85
Net Fixed Assets2.912.842.993.504.624.47
CWIP 0000.120.140.14
Investments 0000.110.110.11
Inventories0.840.861.021.490.880.88
Trade Receivables1.321.572.051.783.254.81
Cash Equivalents 1.101.132.514.745.755.97
Others Assets1.645.976.9011.3213.6515.69
Total Assets 7.8212.3715.4823.0628.4032.07

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Cash Flow From Operating Activity 2.991.512.875.792.320.75
PBT 0.141.562.755.851.795.91
Adjustment 0.040.600.421.930.260.28
Changes in Working Capital 2.81-0.42-0.01-1.320.3-5.42
Tax Paid 0-0.23-0.30-0.67-0.02-0.02
Cash Flow From Investing Activity -2.92-3.96-1.10-4.23-0.940.33
Capex -2.93-0.19-0.43-0.96-1.63-0.31
Net Investments 00.070-0.2900
Others 0-3.85-0.66-2.990.690.64
Cash Flow From Financing Activity 0.962.55-0.390.67-0.37-0.86
Net Proceeds from Shares 0.013.110000
Net Proceeds from Borrowing 0000-0.22-0.25
Interest Paid -0.03-0.30-0.30-0.35-0.43-0.45
Dividend Paid 000000
Others 0.98-0.26-0.091.020.28-0.16
Net Cash Flow 1.030.101.382.231.010.22
PARTICULARSMar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Ratios
ROE (%)90.9429.0823.3336.948.5724.59
ROCE (%)12.2642.4735.9153.1912.4429.24
Asset Turnover Ratio0.070.760.750.830.460.43
PAT to CFO Conversion(x)29.91.341.421.321.840.17
Working Capital Days
Receivable Days86569634477112
Inventory Days5494133293625
Payable Days5,575244140206292615

Gian Life Care Ltd Stock News

Gian Life Care Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Gian Life Care on 21-Nov-2024 16:59 is ₹18.64.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 21-Nov-2024 16:59 the market cap of Gian Life Care stood at ₹19.58.
The latest P/E ratio of Gian Life Care as of 21-Nov-2024 16:59 is 4.80.
The latest P/B ratio of Gian Life Care as of 21-Nov-2024 16:59 is 0.99.
The 52-week high of Gian Life Care is ₹29.00 and the 52-week low is ₹17.01.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Gian Life Care is ₹12.32 ( Cr.) .

About Gian Life Care Ltd

Gian Life Care was incorporated on November 06, 2018, under the provisions of the Companies Act, 2013 by Registrar of Companies, Kanpur. On March 01, 2019 the company took over the entire running business of Gian Pathology and X-Rays, a proprietorship concern of the promoter Arun Kumar Gupta with a view to provide diagnostic and related healthcare tests and services.

Business area of the Company:

The company is engaged in the business of providing diagnostic and related healthcare services. The company provides a wide range of diagnostic tests and services like patient diagnosis services, prevention, and wellness diagnosis services to patients and healthcare providers. The company caters to individual patients, hospitals, corporates and other healthcare providers. The company offers over 1,344 tests including biochemistry, clinical pathology, coagulation, cytogenetics, cytology, hematology, histopathology, immunoassay, microbiology, molecular biology, and radiology services. Gian Life is NABL accredited and ISO 9001:2015 certified company.

Key Events and Milestones:

  • 2018: Incorporation of the Company in the name of ‘Gian Life Care Limited’
  • 2019: Acquired the running business along with substantial assets and liabilities of Gian Pathology and X rays, proprietorship concern of the Promoter.

 

Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.